培訓前后社區醫生對肺炎球菌疫苗認識的調查分析_《華西醫學》

作者：

李峻 ,  董碧蓉 , 舒德芬

四川大學華西醫院老年科（成都，610041）;

關鍵詞：

肺炎球菌疫苗社區醫生培訓老年人群

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

【摘要】　目的　應用調查問卷分析培訓前后成都市社區醫生對肺炎球菌疫苗的認識，為推動社區肺炎球菌疫苗接種奠定基礎。　方法　對215名成都市社區醫生進行肺炎球菌疾病及預防知識的培訓，并在培訓前后行問卷調查，回收問卷并分析。　結果　經培訓，社區醫生提高了對肺炎球菌疾病及疫苗接種知識的掌握程度，加深了對肺炎球菌疾病及疫苗接種重要性的認識。　結論　對社區醫生進行肺炎球菌相關知識的培訓，有利于提高社區醫生對肺炎球菌疫苗接種推薦的專業性和成功率。
【Abstract】　Objective　 To know the community doctors’ understanding of pneumococcal vaccine before and after the education via questionnaire. 　Methods　 A total of 215 community doctors in Chengdu were educated in pneumococcal disease and the prevention knowledge. Questionnaire investigation was performed before and after the education and the results were analyzed.　Results　 After the education, the acknowledgement of pneumococcal vaccination of the community doctors was improved.　Conclusion　 The education of the knowledge of pneumococcal vaccine for the community doctors helps to improve the acknowledgement of pneumococcal vaccination.

引用本文： 李峻,董碧蓉,舒德芬. 培訓前后社區醫生對肺炎球菌疫苗認識的調查分析. 華西醫學, 2011, 26(1): 38-40. doi: 復制

1.	Cripps AW, Leach AJ, Lehmann D. Pneumococcal vaccination in developing countries[J]. Lancet, 2006, 19, 368(9536): 644.
2.	Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations[J]. JAMA, 1993, 270(15): 1826-1831.
3.	WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2007, 82(12): 93-104.
4.	WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2008, 83(42): 373-384.
5.	Christenson B, Hedlund J, Lunbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons[J]. Eur Respir J, 2004, 23(3): 363-368.
6.	Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity[J]. Virol J, 2008, 5: 52.
7.	徐英, 董碧蓉. 23價肺炎球菌多糖疫苗預防老年人下呼吸道感染的效果考察[J]. 中國計劃免疫, 2005, 11(4): 287-291.
8.	Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial[J]. Lancet, 2005, 365(9465): 1139-1146.
9.	Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection[J]. N Engl J Med, 2003, 349(14): 1341-1348.
10.	Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study[J]. Lancet, 2001, 357(9261): 1008-1011.
11.	WHO position paper. Pneumococcal vaccines[J]. Wkly Epidemiol Rec, 2003, 79(14): 110-119.
12.	Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients[J]. Arch Intern Med, 2001, 161 (22): 270-272.
13.	徐英, 董碧蓉. 老年人群接種多價肺炎球菌疫苗的臨床免疫效果與經濟效益[J]. 華西醫學, 2003, 18(3): 442.

1. 　Cripps AW, Leach AJ, Lehmann D. Pneumococcal vaccination in developing countries[J]. Lancet, 2006, 19, 368(9536): 644.
2. 　Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations[J]. JAMA, 1993, 270(15): 1826-1831.
3. 　WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2007, 82(12): 93-104.
4. 　WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2008, 83(42): 373-384.
5. 　Christenson B, Hedlund J, Lunbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons[J]. Eur Respir J, 2004, 23(3): 363-368.
6. 　Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity[J]. Virol J, 2008, 5: 52.
7. 　徐英, 董碧蓉. 23價肺炎球菌多糖疫苗預防老年人下呼吸道感染的效果考察[J]. 中國計劃免疫, 2005, 11(4): 287-291.
8. 　Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial[J]. Lancet, 2005, 365(9465): 1139-1146.
9. 　Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection[J]. N Engl J Med, 2003, 349(14): 1341-1348.
10. 　Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study[J]. Lancet, 2001, 357(9261): 1008-1011.
11. 　WHO position paper. Pneumococcal vaccines[J]. Wkly Epidemiol Rec, 2003, 79(14): 110-119.
12. 　Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients[J]. Arch Intern Med, 2001, 161 (22): 270-272.
13. 　徐英, 董碧蓉. 老年人群接種多價肺炎球菌疫苗的臨床免疫效果與經濟效益[J]. 華西醫學, 2003, 18(3): 442.

《華西醫學》

培訓前后社區醫生對肺炎球菌疫苗認識的調查分析

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《華西醫學》

培訓前后社區醫生對肺炎球菌疫苗認識的調查分析

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料